Horsham, PA (Vocus) October 10, 2009
Electronic CTD is poised to become the preferred format for regulatory submissions in many regions, from South-central Asia to the Pacific Rim to Latin America. Australia and Switzerland have both issued statements of intent to accept eCTD, while many other regions are basing both paper and electronic submission formats on the CTD structure. This three-day conference will include two parallel tracks featuring the following sessions:
The opening plenary sessions will feature speakers from FDA, the European Union, and Health Canada to present up-to-date information on FDA's standards, expectations, and experiences with eCTDs, as well as plans for eCTDs and eSubmissions in the US, EU, and Canada.
"Electronic CTD-formatted submissions have taken hold in the US and are on their way to doing the same in Europe," says Gary M. Gensinger, MBA, Deputy Director, Office of Business Process Support, CDER, FDA. "The 8th Annual Electronic Submissions Conference will discuss current developments in eCTD in the US and Europe, filing CTD-formatted submissions in other markets, and emerging technologies affecting electronic submissions."
Click here to register.
For exhibiting opportunities, contact Shannon Lewis at +1-215-442-6149 or Shannon.Lewis(at)diahome.org.
About the Drug Information Association (DIA)
DIA serves more than 30,000 professionals involved in the biopharmaceutical industry and regulatory affairs worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of the drug discovery and lifecycle management processes. Headquartered in Horsham, PA, USA, and with offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China, the Association is led by its volunteer-based Board of Directors and executive management team. For more information, visit http://www.diahome.org or call 215-442-6100.
Joe (dot) Krasowski (at) diahome (dot) org